417 related articles for article (PubMed ID: 17047284)
1. Enhanced platelet adhesion and aggregation by endothelial cell-derived unusually large multimers of von Willebrand factor.
Kumar RA; Moake JL; Nolasco L; Bergeron AL; Sun C; Dong JF; McIntire LV
Biorheology; 2006; 43(5):681-91. PubMed ID: 17047284
[TBL] [Abstract][Full Text] [Related]
2. Thrombotic thrombocytopenic purpura.
Moake JL
Thromb Haemost; 1995 Jul; 74(1):240-5. PubMed ID: 8578465
[TBL] [Abstract][Full Text] [Related]
3. Thrombotic thrombocytopenic purpura and the haemolytic-uraemic syndrome: evolving concepts of pathogenesis and therapy.
Byrnes JJ; Moake JL
Clin Haematol; 1986 May; 15(2):413-42. PubMed ID: 3524932
[TBL] [Abstract][Full Text] [Related]
4. A novel interpretation of the role of von Willebrand factor in thrombotic microangiopathies based on platelet adhesion studies at high shear rate flow.
Galbusera M; Remuzzi A; Benigni A; Rossi C; Remuzzi G
Am J Kidney Dis; 2000 Oct; 36(4):695-702. PubMed ID: 11007670
[TBL] [Abstract][Full Text] [Related]
5. [Biology of von Willebrand factor].
Girma JP
Nephrol Ther; 2006 Jan; 2 Suppl 2():S143-8. PubMed ID: 17373215
[TBL] [Abstract][Full Text] [Related]
6. Adhesion of platelets to purified solid-phase von Willebrand factor: effects of wall shear rate, ADP, thrombin, and ristocetin.
Olson JD; Zaleski A; Herrmann D; Flood PA
J Lab Clin Med; 1989 Jul; 114(1):6-18. PubMed ID: 2786916
[TBL] [Abstract][Full Text] [Related]
7. Abnormalities of von Willebrand factor multimers in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome.
Moake JL; McPherson PD
Am J Med; 1989 Sep; 87(3N):9N-15N. PubMed ID: 2486537
[TBL] [Abstract][Full Text] [Related]
8. Characterisation of a monoclonal antibody to von Willebrand factor as a potent inhibitor of ristocetin-mediated platelet interaction and platelet adhesion.
Jorieux S; de Romeuf C; Samor B; Goudemand M; Mazurier C
Thromb Haemost; 1987 Jun; 57(3):278-82. PubMed ID: 3116700
[TBL] [Abstract][Full Text] [Related]
9. Abnormally large von Willebrand factor multimers in Henoch-Schönlein purpura.
Casonato A; Pontara E; Bertomoro A; Ossi E; Vincenti M; Girolami A; Borsatti A; Bertaglia G
Am J Hematol; 1996 Jan; 51(1):7-11. PubMed ID: 8571941
[TBL] [Abstract][Full Text] [Related]
10. Increased neonatal platelet deposition on subendothelium under flow conditions: the role of plasma von Willebrand factor.
Shenkman B; Linder N; Savion N; Tamarin I; Dardik R; Kennet G; German B; Varon D
Pediatr Res; 1999 Feb; 45(2):270-5. PubMed ID: 10022601
[TBL] [Abstract][Full Text] [Related]
11. Thrombotic thrombocytopenic purpura: understanding a disease no longer rare.
Moake JL; Chow TW
Am J Med Sci; 1998 Aug; 316(2):105-19. PubMed ID: 9704664
[TBL] [Abstract][Full Text] [Related]
12. von Willebrand factor in the pathophysiology of thrombotic thrombocytopenic purpura.
Moake JL
Clin Lab Sci; 1998; 11(6):362-4. PubMed ID: 10345504
[TBL] [Abstract][Full Text] [Related]
13. Loss of high-molecular-weight von Willebrand factor multimers mainly affects platelet aggregation in patients with aortic stenosis.
Panzer S; Badr Eslam R; Schneller A; Kaider A; Koren D; Eichelberger B; Rosenhek R; Budde U; Lang IM
Thromb Haemost; 2010 Feb; 103(2):408-14. PubMed ID: 20024494
[TBL] [Abstract][Full Text] [Related]
14. Shear stress and the role of high molecular weight von Willebrand factor multimers in thrombus formation.
López JA; Dong JF
Blood Coagul Fibrinolysis; 2005 Apr; 16 Suppl 1():S11-6. PubMed ID: 15849521
[TBL] [Abstract][Full Text] [Related]
15. Endothelial microparticles induce formation of platelet aggregates via a von Willebrand factor/ristocetin dependent pathway, rendering them resistant to dissociation.
Jy W; Jimenez JJ; Mauro LM; Horstman LL; Cheng P; Ahn ER; Bidot CJ; Ahn YS
J Thromb Haemost; 2005 Jun; 3(6):1301-8. PubMed ID: 15946221
[TBL] [Abstract][Full Text] [Related]
16. Generation and breakdown of soluble ultralarge von Willebrand factor multimers.
Turner N; Nolasco L; Moake J
Semin Thromb Hemost; 2012 Feb; 38(1):38-46. PubMed ID: 22314602
[TBL] [Abstract][Full Text] [Related]
17. Involvement of large plasma von Willebrand factor (vWF) multimers and unusually large vWF forms derived from endothelial cells in shear stress-induced platelet aggregation.
Moake JL; Turner NA; Stathopoulos NA; Nolasco LH; Hellums JD
J Clin Invest; 1986 Dec; 78(6):1456-61. PubMed ID: 3491092
[TBL] [Abstract][Full Text] [Related]
18. The aptamer ARC1779 blocks von Willebrand factor-dependent platelet function in patients with thrombotic thrombocytopenic purpura ex vivo.
Mayr FB; Knöbl P; Jilma B; Siller-Matula JM; Wagner PG; Schaub RG; Gilbert JC; Jilma-Stohlawetz P
Transfusion; 2010 May; 50(5):1079-87. PubMed ID: 20070617
[TBL] [Abstract][Full Text] [Related]
19. On the mechanism of plasmin-induced aggregation of human platelets: implication of secreted von Willebrand factor.
Rabhi-Sabile S; de Romeuf C; Pidard D
Thromb Haemost; 1998 Jun; 79(6):1191-8. PubMed ID: 9657447
[TBL] [Abstract][Full Text] [Related]
20. Laboratory diagnosis and molecular classification of von Willebrand disease.
Gadisseur A; Hermans C; Berneman Z; Schroyens W; Deckmyn H; Michiels JJ
Acta Haematol; 2009; 121(2-3):71-84. PubMed ID: 19506352
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
